Bnp Paribas Asset Management Holding S.A. Voyager Therapeutics, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$7.15 - $12.28 $427,705 - $734,577	-59,819 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$8.05 - $14.21 $6,391 - $11,282	794 Added 1.35%	59,819 $755,000
Q1 2020 May 12, 2020	BUY	$6.8 - $14.66 $22,528 - $48,568	3,313 Added 5.95%	59,025 $540,000
Q4 2019 Feb 11, 2020	BUY	$12.82 - $16.85 $714,227 - $938,747	55,712 New	55,712 $777,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $207M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.